Anti-BMR1A/ BMPR1A/ 10q23del monoclonal antibody

Anti-BMR1A/ BMPR1A/ 10q23del antibody for FACS & in-vivo assay

Target products collectionGo to BMPR1A/BMPR1A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0136-Ab-1/ GM-Tg-hg-MP0136-Ab-2Anti-Human BMPR1A monoclonal antibodyHuman
GM-Tg-rg-MP0136-Ab-1/ GM-Tg-rg-MP0136-Ab-2Anti-Rat BMPR1A monoclonal antibodyRat
GM-Tg-mg-MP0136-Ab-1/ GM-Tg-mg-MP0136-Ab-2Anti-Mouse BMPR1A monoclonal antibodyMouse
GM-Tg-cynog-MP0136-Ab-1/ GM-Tg-cynog-MP0136-Ab-2Anti-Cynomolgus/ Rhesus macaque BMPR1A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0136-Ab-1/ GM-Tg-felg-MP0136-Ab-2Anti-Feline BMPR1A monoclonal antibodyFeline
GM-Tg-cang-MP0136-Ab-1/ GM-Tg-cang-MP0136-Ab-2Anti-Canine BMPR1A monoclonal antibodyCanine
GM-Tg-bovg-MP0136-Ab-1/ GM-Tg-bovg-MP0136-Ab-2Anti-Bovine BMPR1A monoclonal antibodyBovine
GM-Tg-equg-MP0136-Ab-1/ GM-Tg-equg-MP0136-Ab-2Anti-Equine BMPR1A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0136-Ab-1/ GM-Tg-hg-MP0136-Ab-2; GM-Tg-rg-MP0136-Ab-1/ GM-Tg-rg-MP0136-Ab-2;
GM-Tg-mg-MP0136-Ab-1/ GM-Tg-mg-MP0136-Ab-2; GM-Tg-cynog-MP0136-Ab-1/ GM-Tg-cynog-MP0136-Ab-2;
GM-Tg-felg-MP0136-Ab-1/ GM-Tg-felg-MP0136-Ab-2; GM-Tg-cang-MP0136-Ab-1/ GM-Tg-cang-MP0136-Ab-2;
GM-Tg-bovg-MP0136-Ab-1/ GM-Tg-bovg-MP0136-Ab-2; GM-Tg-equg-MP0136-Ab-1/ GM-Tg-equg-MP0136-Ab-2
Products NameAnti-BMPR1A monoclonal antibody
Formatmab
Target NameBMPR1A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BMPR1A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species BMR1A/ BMPR1A/ 10q23del VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0136-Ag-1bone morphogenetic protein receptor, type IA (BMPR1A) protein
    ORF Viral VectorpGMLPm003040mouse Bmpr1a Lentivirus plasmid
    ORF Viral VectorvGMLPm003040mouse Bmpr1a Lentivirus particle


    Target information

    Target IDGM-MP0136
    Target NameBMPR1A
    Gene ID657,12166,81507,696898,489077,101089548,404101,100064367
    Gene Symbol and Synonyms10q23del,1110037I22Rik,ACVRLK3,ALK-3,ALK3,Bmpr,BMPR-1A,BMPR-IA,BMPR1A,CD292,SKR5
    Uniprot AccessionP36894,Q78EA7
    Uniprot Entry NameBMR1A_HUMAN,BMR1A_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseCancer
    Gene EnsemblENSG00000107779
    Target ClassificationKinase, Tumor-associated antigen (TAA)

    The target: BMPR1A, gene name: BMPR1A, also named as 10q23del, ACVRLK3, ALK3, CD292, SKR5. The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.